Latest news for CSPC Pharma Gr (OTC:CHJTF) Stock

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC PHARM GROUP LTD ORD by CSPC Pharmaceuticals Group Ltd.

CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced the on-market purchase of 1,318,000 sha...

CSPC Pharmaceutical Executes Share Purchase Plan

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced the on-market purchase of 7 million sha...

CSPC Pharma Buys Back Shares for Award Scheme

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has recently executed an on-market share purchase for...

CSPC Pharmaceutical Buys Shares for Award Scheme

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced the approval of clinical trials in Chin...

CSPC Pharmaceutical's CAR-T Cell Therapy Advances

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced that their Roxadustat Capsules, the fir...

CSPC Pharma's New Anemia Drug Approved in China

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced that its antibody-drug conjugate, SYS60...

CSPC's Novel Cancer Drug Enters U.S. Clinical Trials

Morgan Stanley analyst Sean Wu CFA maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of H...

Buy Rating Affirmed for CSPC Pharmaceutical Amid Positive Financial Projections and Stable Price Target

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited announced that their mRNA Respiratory Syncytial Virus...

CSPC Pharmaceutical's RSV Vaccine Trials Approved

Moderna rival CSPC cleared to study RSV shot in China

CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group Limited has announced that CHL Group, associated with a key s...

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

CSPC Pharma Gr

News

Latest news for CSPC Pharma Gr (OTC:CHJTF) Stock